UA83809U - Process for the preparation of copper-67 (67cu) isotope for treating cancer - Google Patents

Process for the preparation of copper-67 (67cu) isotope for treating cancer

Info

Publication number
UA83809U
UA83809U UAU201305557U UAU201305557U UA83809U UA 83809 U UA83809 U UA 83809U UA U201305557 U UAU201305557 U UA U201305557U UA U201305557 U UAU201305557 U UA U201305557U UA 83809 U UA83809 U UA 83809U
Authority
UA
Ukraine
Prior art keywords
isotope
copper
preparation
treating cancer
diantipyrilpropylmethane
Prior art date
Application number
UAU201305557U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микола Петрович Дикий
Микола Віленович Красносельський
Олена Павлівна Медведєва
Original Assignee
Харьковский Национальный Медицинский Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковский Национальный Медицинский Университет filed Critical Харьковский Национальный Медицинский Университет
Priority to UAU201305557U priority Critical patent/UA83809U/en
Publication of UA83809U publication Critical patent/UA83809U/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for the preparation of copper-67 (67Cu) isotope for treating cancer involves photonuclear technology at linear electron accelerator using bifunctional ligands. (67Cu) extraction is carried out in a hot chamber of irradiated zinc target in the presence of diantipyrilpropylmethane solution in chloroform.
UAU201305557U 2013-04-29 2013-04-29 Process for the preparation of copper-67 (67cu) isotope for treating cancer UA83809U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201305557U UA83809U (en) 2013-04-29 2013-04-29 Process for the preparation of copper-67 (67cu) isotope for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201305557U UA83809U (en) 2013-04-29 2013-04-29 Process for the preparation of copper-67 (67cu) isotope for treating cancer

Publications (1)

Publication Number Publication Date
UA83809U true UA83809U (en) 2013-09-25

Family

ID=52279148

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201305557U UA83809U (en) 2013-04-29 2013-04-29 Process for the preparation of copper-67 (67cu) isotope for treating cancer

Country Status (1)

Country Link
UA (1) UA83809U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183041B2 (en) 2017-04-12 2019-01-22 Vector Vitale Ip Llc Antibacterial composition and its use in treating bacterial infections
US10226484B2 (en) 2014-12-01 2019-03-12 Peter Y Novak Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226484B2 (en) 2014-12-01 2019-03-12 Peter Y Novak Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof
US11484550B2 (en) 2014-12-01 2022-11-01 Vector Vitale Ip Llc Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof
US12011458B2 (en) 2014-12-01 2024-06-18 Vector Vitale Ip Llc Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof
US10183041B2 (en) 2017-04-12 2019-01-22 Vector Vitale Ip Llc Antibacterial composition and its use in treating bacterial infections

Similar Documents

Publication Publication Date Title
GB2521562A (en) Anti-tumor T cell immunity induced by high dose radiation
MX2019005465A (en) Immunotherapeutic tumor treatment method.
BR112018069628A2 (en) solid tumor treatment methods
PH12019500135A1 (en) Methods of treating prostate cancer
TN2016000142A1 (en) Specific anti-cd38 antibodies for treating human cancers.
MX2016007282A (en) Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer.
MX2016002051A (en) Methods and kits for the molecular subtyping of tumors.
MY194341A (en) Method of treating a brain tumor
MX2015012106A (en) Combination of an egfr t790m inhibitor and an egfr inhibitor for the treatment of non-small cell lung cancer.
PH12015502260A1 (en) C. novyi for the treatment of solid tumors in humans
MD20160016A2 (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
EA201591987A1 (en) TREATMENT OF MALIGNANT TUMOR DIHYDROPYRAZINOPIRASINS
RU2014141365A (en) METHOD FOR INTRODUCING ANTITUMOR AGENT
SG191336A1 (en) Compositions and methods of aloe polysaccharides
MX2016016388A (en) Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds.
AR112405A1 (en) TREATMENT OF TRIPLE NEGATIVE BREAST CANCER OR COLORECTAL CANCER WITH LIVER METASTASES
UA83809U (en) Process for the preparation of copper-67 (67cu) isotope for treating cancer
WO2014160967A3 (en) C. novyi for the treatment of solid tumors in non-human animals
PH12016500677A1 (en) Specific anti-cd38 antibodies for treating human cancers
MX2017013666A (en) Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancer.
MX2019014489A (en) Dosing schedule for tesetaxel and capecitabine.
RU2013130449A (en) METHOD FOR COMBINED TREATMENT OF RECTAL GUT CANCER
WO2012143713A3 (en) Radioactive solutions for treating cancer
EP3558437A4 (en) Delivery system for intensity modulated high dose rate brachytherapy with intermediate energy brachytherapy isotopes
MX2017013669A (en) Compositions for the treatment of cancer.